Chizu Fukushima Selected Research

pranlukast

8/2012	Effects of a short course of pranlukast combined with systemic corticosteroid on acute asthma exacerbation induced by upper respiratory tract infection.
1/2008	Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists.
7/2006	Effects of anti-inflammatory therapies on recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma.
2/2005	Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism.
5/2004	The position of pranlukast, a cysteinyl leukotriene receptor antagonist, in the long-term treatment of asthma. 5-year follow-up study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chizu Fukushima Research Topics

Disease

31	Asthma (Bronchial Asthma) 04/2022 - 07/2002
15	Inflammation (Inflammations) 01/2020 - 01/2003
7	Respiratory Syncytial Virus Infections 01/2012 - 02/2004
6	Infections 12/2019 - 11/2005
3	Familial Mediterranean Fever (Periodic Disease) 01/2020 - 01/2017
3	Virus Diseases (Viral Diseases) 08/2012 - 06/2007
2	Allergic Bronchopulmonary Aspergillosis 04/2022 - 12/2019
2	Castleman Disease (Castleman's Disease) 12/2020 - 07/2020
2	Lymphadenopathy 12/2020 - 07/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 08/2012 - 01/2008
2	Dyspnea (Shortness of Breath) 01/2012 - 02/2008
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2012 - 01/2009
2	Eosinophilia 01/2006 - 02/2004
2	Oral Candidiasis (Thrush) 09/2005 - 06/2003
1	Pulmonary Aspergillosis 04/2022
1	Ulcerative Colitis 11/2021
1	Rheumatoid Arthritis 07/2020
1	Amyloidosis 01/2020
1	Invasive Pulmonary Aspergillosis 12/2019
1	Focal Nodular Hyperplasia 07/2019
1	Disease Progression 12/2018
1	Fever (Fevers) 12/2018
1	Human Influenza (Influenza) 08/2012
1	Respiratory Hypersensitivity 01/2012
1	Congenital Abnormalities (Deformity) 01/2012
1	Relapsing Polychondritis 01/2012
1	Edema (Dropsy) 01/2012
1	Respiratory Sounds (Crackle) 02/2008
1	Pulmonary Embolism 02/2008
1	Coinfection 01/2008
1	Chylothorax 10/2007

Drug/Important Bio-Agent (IBA)

13	AllergensIBA 08/2014 - 01/2003
12	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 07/2002
8	CytokinesIBA 04/2022 - 01/2003
5	LeukotrienesIBA 02/2014 - 08/2003
5	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 02/2014 - 05/2004
5	pranlukastIBA 08/2012 - 05/2004
5	Interleukin-10 (Interleukin 10)IBA 01/2012 - 11/2005
5	Interleukin-5 (Interleukin 5)IBA 01/2012 - 02/2004
4	tocilizumab (atlizumab)FDA Link 12/2020 - 12/2018
4	Interleukin-12 (IL 12)IBA 08/2014 - 11/2005
4	NF-kappa B (NF-kB)IBA 01/2007 - 01/2003
3	InterleukinsIBA 04/2022 - 11/2005
3	C-Reactive ProteinIBA 12/2020 - 12/2018
3	Colchicine FDA LinkGeneric 01/2020 - 01/2017
3	Dexamethasone (Maxidex)FDA LinkGeneric 12/2019 - 07/2006
3	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2008
3	cysteinyl-leukotrieneIBA 02/2014 - 09/2004
3	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2013 - 07/2006
3	AcetaldehydeIBA 01/2012 - 09/2003
3	Immunoglobulin E (IgE)IBA 01/2012 - 01/2003
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2012 - 09/2003
3	SteroidsIBA 02/2008 - 07/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022 - 01/2003
2	AlbuminsIBA 12/2020 - 07/2020
2	Hemoglobins (Hemoglobin)IBA 12/2020 - 07/2020
2	Sirolimus (Rapamycin)FDA Link 12/2020 - 07/2020
2	Itraconazole (Sporanox)FDA LinkGeneric 12/2019 - 01/2013
2	AntigensIBA 12/2019 - 08/2012
2	InterferonsIBA 08/2014 - 01/2012
2	Prednisolone (Predate)FDA LinkGeneric 08/2012 - 07/2002
2	SmokeIBA 01/2007 - 09/2003
2	Viral RNAIBA 07/2006 - 11/2005
2	Bronchodilator Agents (Bronchodilators)IBA 11/2005 - 07/2005
2	Tacrolimus (Prograf)FDA LinkGeneric 12/2004 - 09/2004
1	Interleukin-33IBA 04/2022
1	golimumab FDA Link 11/2021
1	Interleukin-6 InhibitorsIBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Antirheumatic Agents (DMARD)IBA 07/2020
1	Infliximab (Remicade)FDA Link 07/2020
1	Biosimilar PharmaceuticalsIBA 07/2020
1	Biological ProductsIBA 07/2020
1	Biomarkers (Surrogate Marker)IBA 07/2020
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2020
1	Formoterol Fumarate (Oxis)FDA Link 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	tulobuterolIBA 01/2020
1	liposomal amphotericin B FDA Link 12/2019
1	Sulfates (Sulfates, Inorganic)IBA 09/2019
1	Oral ContraceptivesIBA 07/2019
1	PyrinIBA 12/2018
1	InflammasomesIBA 12/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 12/2018
1	Interleukin-17 (Interleukin 17)IBA 08/2014
1	dectin 1IBA 08/2014
1	RNA (Ribonucleic Acid)IBA 08/2012
1	SolventsIBA 01/2012
1	Volatile Organic CompoundsIBA 01/2012
1	Proteoglycans (Proteoglycan)IBA 01/2012
1	Endocrine DisruptorsIBA 01/2012
1	Interleukin-13IBA 07/2010
1	TeaIBA 04/2009
1	Heparin (Liquaemin)FDA LinkGeneric 02/2008
1	Monoclonal AntibodiesIBA 01/2008
1	Triglycerides (Triacylglycerol)IBA 10/2007
1	Air Pollutants (Pollutants, Air)IBA 01/2007

Therapy/Procedure

7	Therapeutics 12/2019 - 07/2005
1	Ligation 10/2007